KR19990044618A - 면역억제제 - Google Patents

면역억제제 Download PDF

Info

Publication number
KR19990044618A
KR19990044618A KR1019980701869A KR19980701869A KR19990044618A KR 19990044618 A KR19990044618 A KR 19990044618A KR 1019980701869 A KR1019980701869 A KR 1019980701869A KR 19980701869 A KR19980701869 A KR 19980701869A KR 19990044618 A KR19990044618 A KR 19990044618A
Authority
KR
South Korea
Prior art keywords
group
ethyl
dimethoxyphenyl
quinoline
carboxylate
Prior art date
Application number
KR1019980701869A
Other languages
English (en)
Korean (ko)
Inventor
하루히꼬 마끼노
다까시 소다
요시까즈 오따
Original Assignee
다케다 야쿠힌 고교 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 다케다 야쿠힌 고교 가부시키가이샤 filed Critical 다케다 야쿠힌 고교 가부시키가이샤
Publication of KR19990044618A publication Critical patent/KR19990044618A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1019980701869A 1995-09-13 1996-06-19 면역억제제 KR19990044618A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP23570495 1995-09-13
JP95-235704 1995-09-13

Publications (1)

Publication Number Publication Date
KR19990044618A true KR19990044618A (ko) 1999-06-25

Family

ID=16990000

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019980701869A KR19990044618A (ko) 1995-09-13 1996-06-19 면역억제제

Country Status (10)

Country Link
EP (1) EP0850061A1 (no)
KR (1) KR19990044618A (no)
CN (1) CN1195988A (no)
AU (1) AU6137396A (no)
BR (1) BR9610314A (no)
CA (1) CA2226915A1 (no)
HU (1) HUP9900169A2 (no)
NO (1) NO980788L (no)
NZ (1) NZ310561A (no)
WO (1) WO1997009984A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0941987A1 (de) * 1998-03-13 1999-09-15 Lonza A.G. Verfahren zur Herstellung von 2-Amino-4,5,3',4'-tetramethoxybenzophenon
JP2002517486A (ja) 1998-06-12 2002-06-18 バーテックス ファーマシューティカルズ インコーポレイテッド ｐ３８のインヒビター
EP1277740A1 (en) * 1998-06-12 2003-01-22 Vertex Pharmaceuticals Incorporated Inhibitors of p38
DE19853487A1 (de) 1998-11-19 2000-05-25 Fumapharm Ag Muri Verwendung von Dialkylfumaraten
AU2004269903B2 (en) 2003-09-09 2010-09-02 Biogen International Gmbh The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma
EP2680007A1 (en) 2007-02-08 2014-01-01 Biogen Idec MA Inc. Nrf2 screening assays and related methods and compositions
CN102050780B (zh) * 2010-11-18 2012-05-02 中国科学院昆明植物研究所 喹啉衍生物,其药物组合物及其用途
US11098052B2 (en) 2016-03-02 2021-08-24 Arizona Board Of Regents On Behalf Of Arizona State University 4-azapodophylotoxins compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU633471B2 (en) * 1987-08-26 1993-02-04 Biogen Idec Ma Inc. Biological materials, processes for producing biological materials and for using such materials in therapy
KR0148009B1 (ko) * 1988-05-27 1998-08-01 그래고리 비. 아보트 인터루킨-1 억제제
JP2863265B2 (ja) * 1989-05-19 1999-03-03 ハダサ メディカル オーガニゼーション インターロイキン１インヒビター
US6238875B1 (en) * 1991-03-12 2001-05-29 The Scripps Research Institute Diagnostic methods useful in the characterization of lymphoproliferative disease characterized by increased EPR-1
TW232013B (no) * 1992-04-24 1994-10-11 Takeda Pharm Industry Co Ltd
WO1994007498A1 (en) * 1992-10-07 1994-04-14 Sumitomo Pharmaceuticals Company, Limited Pharmaceutical composition for inhibiting tumor necrosis factor production
JPH06340658A (ja) * 1993-04-08 1994-12-13 Kyowa Hakko Kogyo Co Ltd ベンゾイミダゾール誘導体
IL111743A0 (en) * 1993-12-08 1995-01-24 Intermune Life Sciences Inc Recombinant genes expressing pp14

Also Published As

Publication number Publication date
CA2226915A1 (en) 1997-03-20
WO1997009984A1 (en) 1997-03-20
EP0850061A1 (en) 1998-07-01
CN1195988A (zh) 1998-10-14
AU6137396A (en) 1997-04-01
NZ310561A (en) 1999-07-29
NO980788L (no) 1998-03-31
NO980788D0 (no) 1998-02-25
BR9610314A (pt) 1999-07-06
HUP9900169A2 (hu) 2000-03-28

Similar Documents

Publication Publication Date Title
KR101903204B1 (ko) 복소환 아민 및 이의 용도
EP3409667B1 (en) Amide compounds for the treatment of hiv infections
CA3210224A1 (en) Cdk inhibitors and methods of use thereof
KR20010043134A (ko) 위산 분비를 억제하는 이미다조 피리딘 유도체
WO2013101281A1 (en) Methods and compositions for treating parkinson's disease
JP2020529968A (ja) 置換５員および６員複素環式化合物、その調製方法、薬剤の組み合わせおよびその使用
CN114437035A (zh) 一种抑制并降解irak4的化合物及其药物组合物和药学上的应用
US20220370458A1 (en) Shp2 inhibitor monotherapy and uses thereof
US20210087180A1 (en) Modulators of STING (Stimulator of Interferon Genes)
US20200297704A1 (en) Novel pharmaceutical composition and use thereof
US20180318304A1 (en) Methods of Using BTK Inhibitors to Treat Dermatoses
KR19990044618A (ko) 면역억제제
JPH1067658A (ja) 免疫抑制剤
US6653476B2 (en) Thienopyridine derivatives, their production and use
US20240002362A1 (en) Deuterated 2-arylheterocycle-3-oxo-2,3- dihydropyridazine-4-carboxamide inhibitor and preparation method therefor and application thereof
JP2016527228A (ja) 新規抗マラリア薬
CN113214230B (zh) 2-取代吡唑氨基-4-取代氨基-5-嘧啶甲酰胺类化合物、组合物及其应用
KR20080014017A (ko) (5ｚ)-5-(6-퀴녹살리닐메틸리덴)-2-[(2,6-디클로로페닐)아미노]-1,3-티아졸-4(5ｈ)-온
JP4056589B2 (ja) 複素環化合物、その製造法および用途
CZ280883B6 (cs) 3-/1H-Indazol-3-yl/-4-pyridinaminy, způsob a meziprodukty pro jejich přípravu a jejich použití jako léčiv
CN113416181A (zh) 喹唑啉类衍生物及其用途
CN113272295A (zh) 含有哌嗪酮的喹唑啉二酮盐类化合物、其制备方法、药物组合物和用途
CN115919859A (zh) 一种杂芳基衍生物的药物组合物及其在医药上的应用

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid